The progression-free survival ratio as outcome measure in recurrent ovarian carcinoma patients: Current and future perspectives

The progression-free survival ratio as outcome measure in recurrent ovarian carcinoma patients: Current and future perspectives

Objective: Clinical efficacy of cytostatic anticancer agents can be determined with the progression-free survival (PFS) ratio. This outcome measure compares PFS achieved by a new treatment (PFS2) to the PFS of the most recent treatment on which the patient has experienced progression (PFS1). Clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Nienke van de Kruis (Author), Phyllis van der Ploeg (Author), Jody H.C. Wilting (Author), M. Caroline Vos (Author), Anna M.J. Thijs (Author), Joanne de Hullu (Author), Petronella B. Ottevanger (Author), Christianne Lok (Author), Jurgen M.J. Piek (Author)
Format: Book
Published: Elsevier, 2022-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items